First-line treatment of ovarian cancer: questions and controversies to address

by Jonathan A. Ledermann
Published 2018-04-01

Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer

by Jonathan A. Ledermann, Eric Pujade-Lauraine
Published 2019-05-01

Treatment options in recurrent ovarian cancer: latest evidence and clinical potential

by Daniela Luvero, Andrea Milani, Jonathan A. Ledermann
Published 2014-09-01

ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies

by Jonathan A Ledermann, Ilaria Betella, Maria Del Grande, Francesco Multinu, Cristiana Sessa, Ilaria Colombo, Eleonora Zaccarelli, Federica Tomao, Antonio Gonzalez-Martin
Published 2020-11-01